期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors
1
作者 Yin-How Wong Hun-Yee Tan +3 位作者 Azahari Kasbollah Basri Johan Jeet Abdullah Rajendra Udyavara Acharya Chai-Hong Yeong 《World Journal of Experimental Medicine》 2020年第2期10-25,共16页
BACKGROUND Liver cancer is the 6 th most common cancer in the world and the 4 th most common death from cancer worldwide.Hepatic radioembolization is a minimally invasive treatment involving intraarterial administrati... BACKGROUND Liver cancer is the 6 th most common cancer in the world and the 4 th most common death from cancer worldwide.Hepatic radioembolization is a minimally invasive treatment involving intraarterial administration of radioembolic microspheres.AIM To develop a neutron-activated,biodegradable and theranostics samarium-153 acetylacetonate(153SmAcAc)-poly-L-lactic acid(PLLA)microsphere for intraarterial radioembolization of hepatic tumors.METHODS Microspheres with different concentrations of 152SmAcAc(i.e.,100%,150%,175%and 200%w/w)were prepared by solvent evaporation method.The microspheres were then activated using a nuclear reactor in a neutron flux of 2×10^12n/cm^2/s^1,converting 152Sm to Samarium-153(153)Sm)via 152Sm(n,γ) 153Sm reaction.The SmAcAc-PLLA microspheres before and after neutron activation were characterized using scanning electron microscope,energy dispersive X-ray spectroscopy,particle size analysis,Fourier transform infrared spectroscopy,thermo-gravimetric analysis and gamma spectroscopy.The in-vitro radiolabeling efficiency was also tested in both 0.9% sodium chloride solution and human blood plasma over a duration of 550 h.RESULTS The SmAcAc-PLLA microspheres with different SmAcAc contents remained spherical before and after neutron activation.The mean diameter of the microspheres was about 35μm.Specific activity achieved for 153SmAcAc-PLLA microspheres with 100%,150%,175%and 200%(w/w)SmAcAc after 3 h neutron activation were 1.7±0.05,2.5±0.05,2.7±0.07,and 2.8±0.09 GBq/g,respectively.The activity of per microspheres were determined as 48.36±1.33,74.10±1.65,97.87±2.48,and 109.83±3.71 Bq for 153SmAcAc-PLLA microspheres with 100%,150%,175%and 200%(w/w)SmAcAc.The energy dispersive X-ray and gamma spectrometry showed that no elemental and radioactive impurities present in the microspheres after neutron activation.Retention efficiency of 153Sm in the SmAcAc-PLLA microspheres was excellent(approximately 99%)in both 0.9%sodium chloride solution and human blood plasma over a duration of 550 h.CONCLUSION The 153SmAcAc-PLLA microsphere is potentially useful for hepatic radioembolization due to their biodegradability,favorable physicochemical characteristics and excellent radiolabeling efficiency.The synthesis of the formulation does not involve ionizing radiation and hence reducing the complication and cost of production. 展开更多
关键词 RADIOEMBOLIZATION samarium-153 Yittrium-90 BIODEGRADABLE microsphere Liver tumors NEUTRON activation
下载PDF
^(153)Sm-EDTMP治疗骨转移癌疗效分析
2
作者 马玉波 黄钢 +1 位作者 刘建军 施鹤海 《上海第二医科大学学报》 CSCD 北大核心 2005年第3期273-275,共3页
目的评价153Sm-EDTMP对骨转移癌的临床疗效。方法对确认癌症骨转移的380例患者,静脉给药153Sm-EDTMP0.8~1.0mCi/kg体重,然后从临床表现和骨扫描影像等方面,评价和分析其疗效。结果骨转移灶疼痛缓解总有效率67.50%。骨痛缓解时间2~24周... 目的评价153Sm-EDTMP对骨转移癌的临床疗效。方法对确认癌症骨转移的380例患者,静脉给药153Sm-EDTMP0.8~1.0mCi/kg体重,然后从临床表现和骨扫描影像等方面,评价和分析其疗效。结果骨转移灶疼痛缓解总有效率67.50%。骨痛缓解时间2~24周,平均(5.8±3.4)周。生活质量(KPS评分)平均升高10%。治疗后骨转移灶数目较治疗前明显减少(P<0.001),其代谢活性即ROI比值(T/NT)显著减低(P<0.001)。治疗后WBC和PLT可有一过性下降。结论作为骨转移癌镇痛治疗剂,153Sm-EDTMP能有效缓解疼痛,减少甚至消退转移灶,有较高的临床应用价值。 展开更多
关键词 ^153SM-EDTMP 骨转移癌 治疗后 缓解 疼痛 疗效分析 骨痛 代谢活性 数目 消退
下载PDF
来昔决南钐[^(153)Sm]注射液质量控制标准 被引量:1
3
作者 付博 王晓静 +2 位作者 叶肇云 张云 张文在 《同位素》 CAS 2015年第3期140-147,共8页
建立了来昔决南钐[153Sm]注射液的质量控制指标及方法,主要包括pH检查、细菌内毒素检查、无菌检查、性状鉴别、含游离依地四膦酸量、来昔决南钐含量、放射性核纯度、放化纯度、放射性浓度。分析方法适用于来昔决南钐[153Sm]注射液的常... 建立了来昔决南钐[153Sm]注射液的质量控制指标及方法,主要包括pH检查、细菌内毒素检查、无菌检查、性状鉴别、含游离依地四膦酸量、来昔决南钐含量、放射性核纯度、放化纯度、放射性浓度。分析方法适用于来昔决南钐[153Sm]注射液的常规检验,为该药的质量控制提供了可靠的分析手段。 展开更多
关键词 放射性药物 来昔决南钐[^153Sm]注射液 质量控制
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部